v3.26.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash flows from operating activities    
Net income $ 6.1 $ 599.2
Adjustments to reconcile net income to net cash flows from operating activities:    
Depreciation and amortization 153.8 143.1
Equity-based compensation 336.6 287.1
Non-cash performance allocations and incentive fees, net 686.7 13.1
Non-cash principal investment (income) loss (241.2) (50.2)
Other non-cash amounts (2.5) 35.9
Consolidated Funds related:    
Realized/unrealized (gain) loss on investments of Consolidated Funds 156.3 (100.1)
Realized/unrealized (gain) loss from loans payable of Consolidated Funds (95.4) (76.0)
Purchases of investments by Consolidated Funds (8,355.0) (8,990.3)
Proceeds from sales and settlements of investments by Consolidated Funds 6,495.1 5,169.3
Non-cash interest income, net (13.9) (13.0)
Change in cash and cash equivalents held at Consolidated Funds 462.2 317.1
Change in other receivables held at Consolidated Funds (101.4) (8.0)
Change in other liabilities held at Consolidated Funds (421.7) 65.3
Purchases of investments (340.2) (251.1)
Proceeds from the sale of investments 561.4 664.0
Payments of contingent consideration (14.8) (2.7)
Change in deferred taxes, net (109.0) (67.5)
Change in due from affiliates and other receivables 0.9 (8.7)
Change in deposits and other 19.8 (25.4)
Change in accounts payable, accrued expenses and other liabilities (116.9) 37.8
Change in accrued compensation and benefits (187.4) (61.4)
Change in due to affiliates 20.6 25.1
Change in lease right-of-use assets and lease liabilities (11.7) (9.7)
Change in deferred revenue 229.8 226.7
Net cash used in operating activities (881.8) (2,080.4)
Cash flows from investing activities    
Purchases of fixed assets, net (87.5) (57.4)
Net cash used in investing activities (87.5) (57.4)
Cash flows from financing activities    
Issuance of 5.05% senior notes due 2035, net of financing costs 0.0 792.9
Payments on CLO borrowings (67.9) (52.0)
Proceeds from CLO borrowings, net of financing costs 97.9 64.8
Net borrowings on loans payable of Consolidated Funds 1,336.9 2,755.1
Dividends to common shareholders (376.6) (379.2)
Contributions from non-controlling interest holders 867.6 599.1
Distributions to non-controlling interest holders (323.0) (308.1)
Common shares repurchased and net share settlement of equity-based awards (719.3) (482.8)
Change in due to/from affiliates financing activities (212.1) 25.6
Net cash provided by financing activities 603.5 3,015.4
Effect of foreign exchange rate changes (23.5) 82.3
Increase (decrease) in cash, cash equivalents and restricted cash (389.3) 959.9
Cash, cash equivalents and restricted cash, beginning of period 1,973.6 1,266.5
Cash, cash equivalents and restricted cash, end of period 1,584.3 2,226.4
Supplemental non-cash disclosures    
Initial consolidation of Consolidated Funds 649.3 55.0
Net asset impact of deconsolidation of Consolidated Funds (873.4) (512.5)
Reconciliation of cash, cash equivalents and restricted cash, end of period:    
Cash and cash equivalents 1,583.5 2,221.7
Restricted cash 0.8 4.7
Total cash, cash equivalents and restricted cash, end of period 1,584.3 2,226.4
Cash and cash equivalents held at Consolidated Funds $ 1,021.5 $ 1,037.3